247 related articles for article (PubMed ID: 27221964)
21. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.
Benharroch D; Einav I; Feldman A; Levy A; Ariad S; Gopas J
APMIS; 2010 May; 118(5):339-45. PubMed ID: 20477808
[TBL] [Abstract][Full Text] [Related]
23. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity.
Hinz M; Lemke P; Anagnostopoulos I; Hacker C; Krappmann D; Mathas S; Dörken B; Zenke M; Stein H; Scheidereit C
J Exp Med; 2002 Sep; 196(5):605-17. PubMed ID: 12208876
[TBL] [Abstract][Full Text] [Related]
24. The molecular mechanisms of classic Hodgkin's lymphoma.
Felberbaum RS
Yale J Biol Med; 2005 Jul; 78(4):203-10. PubMed ID: 16720015
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.
Emmerich F; Meiser M; Hummel M; Demel G; Foss HD; Jundt F; Mathas S; Krappmann D; Scheidereit C; Stein H; Dörken B
Blood; 1999 Nov; 94(9):3129-34. PubMed ID: 10556199
[TBL] [Abstract][Full Text] [Related]
26. CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.
Wright CW; Rumble JM; Duckett CS
J Biol Chem; 2007 Apr; 282(14):10252-62. PubMed ID: 17261581
[TBL] [Abstract][Full Text] [Related]
27. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
[TBL] [Abstract][Full Text] [Related]
28. Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.
von Hoff L; Kärgel E; Franke V; McShane E; Schulz-Beiss KW; Patone G; Schleussner N; Kolesnichenko M; Hübner N; Daumke O; Selbach M; Akalin A; Mathas S; Scheidereit C
Blood; 2019 Mar; 133(13):1489-1494. PubMed ID: 30696620
[TBL] [Abstract][Full Text] [Related]
29. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α production.
Incrocci R; McAloon J; Montesano M; Bardahl J; Vagvala S; Stone A; Swanson-Mungerson M
J Med Virol; 2019 May; 91(5):845-855. PubMed ID: 30609049
[TBL] [Abstract][Full Text] [Related]
31. Molecular biology of Hodgkin lymphoma.
Weniger MA; Küppers R
Leukemia; 2021 Apr; 35(4):968-981. PubMed ID: 33686198
[TBL] [Abstract][Full Text] [Related]
32. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.
Carbone A; Gloghini A; Caruso A; De Paoli P; Dolcetti R
Int J Cancer; 2017 Mar; 140(6):1233-1245. PubMed ID: 27750386
[TBL] [Abstract][Full Text] [Related]
33. Immunobiology and pathophysiology of Hodgkin lymphomas.
Poppema S
Hematology Am Soc Hematol Educ Program; 2005; ():231-8. PubMed ID: 16304386
[TBL] [Abstract][Full Text] [Related]
34. The molecular pathogenesis of Hodgkin lymphoma.
Farrell K; Jarrett RF
Histopathology; 2011 Jan; 58(1):15-25. PubMed ID: 21261680
[TBL] [Abstract][Full Text] [Related]
35. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.
Bräuninger A; Schmitz R; Bechtel D; Renné C; Hansmann ML; Küppers R
Int J Cancer; 2006 Apr; 118(8):1853-61. PubMed ID: 16385563
[TBL] [Abstract][Full Text] [Related]
36. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.
Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N
Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613
[TBL] [Abstract][Full Text] [Related]
37. New insights in the biology of Hodgkin lymphoma.
Küppers R
Hematology Am Soc Hematol Educ Program; 2012; 2012():328-34. PubMed ID: 23233600
[TBL] [Abstract][Full Text] [Related]
38. Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma.
Song Z; Wei W; Xiao W; Al-Saleem ED; Nejati R; Chen L; Yin J; Fabrizio J; Petrus MN; Waldmann TA; Yang Y
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28980-28991. PubMed ID: 33139544
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin's lymphoma and CD30 signal transduction.
Horie R; Higashihara M; Watanabe T
Int J Hematol; 2003 Jan; 77(1):37-47. PubMed ID: 12568298
[TBL] [Abstract][Full Text] [Related]
40. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
